MARCHF5 and acute lymphoblastic leukemia: Although our biological data above show that MARCH5 is a clear modulator of the response to ABT-737, its expression was not identified as a significant determinant of sensitivity in the multiple regression analysis of the ‘ALL’ cell line group.